Development of phenol-grafted polyglucuronic acid and its application to extrusion-based bioprinting inks

In this present work, we developed a phenol grafted polyglucuronic acid (PGU) and investigated the usefulness in tissue engineering field by using this derivative as a bioink component allowing gelation in extrusion-based 3D bioprinting. The PGU derivative was obtained by conjugating with tyramine,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carbohydrate polymers 2022-02, Vol.277, p.118820-118820, Article 118820
Hauptverfasser: Sakai, Shinji, Kotani, Takashi, Harada, Ryohei, Goto, Ryota, Morita, Takahiro, Bouissil, Soukaina, Dubessay, Pascal, Pierre, Guillaume, Michaud, Philippe, El Boutachfaiti, Redouan, Nakahata, Masaki, Kojima, Masaru, Petit, Emmanuel, Delattre, Cédric
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this present work, we developed a phenol grafted polyglucuronic acid (PGU) and investigated the usefulness in tissue engineering field by using this derivative as a bioink component allowing gelation in extrusion-based 3D bioprinting. The PGU derivative was obtained by conjugating with tyramine, and the aqueous solution of the derivative was curable through a horseradish peroxidase (HRP)-catalyzed reaction. From 2.0 w/v% solution of the derivative containing 5 U/mL HRP, hydrogel constructs were successfully obtained with a good shape fidelity to blueprints. Mouse fibroblasts and human hepatoma cells enclosed in the printed constructs showed about 95% viability the day after printing and survived for 11 days of study without a remarkable decrease in viability. These results demonstrate the great potential of the PGU derivative in tissue engineering field especially as an ink component of extrusion-based 3D bioprinting.
ISSN:0144-8617
1879-1344
DOI:10.1016/j.carbpol.2021.118820